Keswani Sanjay Chandru bought NBIX
June 2, 2025 · Form 4 insider transaction
Keswani Sanjay Chandru bought 70,101 shares of Neurocrine Biosciences, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
70,101
Price
$0.00
Total value
N/A
InsiderKeswani Sanjay Chandru
Role—
SecurityStock Option
Transaction codeA: Grant or award
Transaction dateJune 2, 2025
Filing dateJune 4, 2025
Shares owned after70,101
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents option of which 1/4th of the shares underlying the option becomes vested and exercisable on June 2, 2026 and an additional 1/48th of the shares underlying the option becomes vested and excercisable each month thereafter.